NCKAP1L
Basic information
Region (hg38): 12:54497752-54548243
Previous symbols: [ "HEM1" ]
Links
Phenotypes
GenCC
Source:
- immunodeficiency 72 with autoinflammation (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 72 with autoinflammation and lymphoproliferation | AR | Allergy/Immunology/Infectious | The condition can involve early-onset and severe infections, as well as other immunologic manifestations, and awareness may allow early and aggressive treatment of infections; Medical management of autoimmune disease (with immunomodulatory agents) has been described as beneficial in some individuals | Allergy/Immunology/Infectious | 32647003 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NCKAP1L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 101 | 11 | 112 | |||
missense | 95 | 106 | ||||
nonsense | 3 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 9 | 24 | 4 | 37 | ||
non coding | 70 | 15 | 86 | |||
Total | 0 | 6 | 103 | 176 | 29 |
Variants in NCKAP1L
This is a list of pathogenic ClinVar variants found in the NCKAP1L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-54497791-T-C | Immunodeficiency 72 with autoinflammation | Likely pathogenic (-) | ||
12-54497801-A-C | Likely benign (Aug 25, 2023) | |||
12-54497807-T-C | Likely benign (Aug 25, 2023) | |||
12-54497847-G-T | not specified | Uncertain significance (May 12, 2024) | ||
12-54497850-C-T | not specified | Uncertain significance (Jan 06, 2023) | ||
12-54497852-C-T | Likely benign (Dec 09, 2023) | |||
12-54497872-G-A | Uncertain significance (Mar 04, 2022) | |||
12-54497879-T-C | Likely benign (Nov 27, 2023) | |||
12-54497887-A-G | not specified | Uncertain significance (May 29, 2022) | ||
12-54497899-T-C | Likely benign (May 09, 2022) | |||
12-54497906-T-TG | Likely benign (Nov 24, 2023) | |||
12-54497907-G-A | Likely benign (Jan 01, 2024) | |||
12-54497908-G-T | Likely benign (Aug 29, 2023) | |||
12-54499347-C-T | Likely benign (Jan 12, 2023) | |||
12-54499351-G-A | Likely benign (May 29, 2023) | |||
12-54499362-C-T | Uncertain significance (May 28, 2022) | |||
12-54499410-C-T | not specified | Uncertain significance (Sep 17, 2022) | ||
12-54499417-C-A | Likely benign (Aug 28, 2022) | |||
12-54499424-A-G | Likely benign (Dec 23, 2023) | |||
12-54499448-G-C | NCKAP1L-related disorder | Benign (Jan 20, 2024) | ||
12-54499455-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
12-54499463-A-G | not specified | Uncertain significance (Dec 21, 2023) | ||
12-54499468-G-A | Uncertain significance (Dec 18, 2023) | |||
12-54499483-C-G | Likely benign (Dec 01, 2022) | |||
12-54500536-C-T | Likely benign (Dec 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NCKAP1L | protein_coding | protein_coding | ENST00000293373 | 31 | 46232 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.855 | 0.145 | 125707 | 0 | 41 | 125748 | 0.000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.48 | 456 | 631 | 0.723 | 0.0000341 | 7438 |
Missense in Polyphen | 134 | 217.54 | 0.61597 | 2504 | ||
Synonymous | 0.0300 | 229 | 230 | 0.997 | 0.0000114 | 2171 |
Loss of Function | 5.88 | 13 | 63.6 | 0.204 | 0.00000336 | 730 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.000229 | 0.000229 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Essential hematopoietic-specific regulator of the actin cytoskeleton (Probable). Controls lymphocyte development, activation, proliferation and homeostasis, erythrocyte membrane stability, as well as phagocytosis and migration by neutrophils and macrophages (PubMed:16417406, PubMed:17696648). Component of the WAVE2 complex which signals downstream of RAC to stimulate F- actin polymerization. Required for stabilization and/or translation of the WAVE2 complex proteins in hematopoietic cells (By similarity). Exhibits complex cycles of activation and inhibition to generate waves of propagating the assembly with actin (PubMed:16417406). Also involved in mechanisms WAVE- independent to regulate myosin and actin polymerization during neutrophil chemotaxis (PubMed:17696648). {ECO:0000250|UniProtKB:Q8K1X4, ECO:0000269|PubMed:16417406, ECO:0000269|PubMed:17696648, ECO:0000303|PubMed:20969869}.;
- Pathway
- Regulation of actin cytoskeleton - Homo sapiens (human);Hematopoietic Stem Cell Differentiation;Microglia Pathogen Phagocytosis Pathway;TYROBP Causal Network;Neutrophil degranulation;Signal Transduction;VEGFA-VEGFR2 Pathway;Fcgamma receptor (FCGR) dependent phagocytosis;Innate Immune System;Immune System;RHO GTPases Activate WASPs and WAVEs;RHO GTPase Effectors;Signaling by Rho GTPases;Regulation of actin dynamics for phagocytic cup formation;Signaling by VEGF;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.664
- rvis_EVS
- -0.46
- rvis_percentile_EVS
- 23.69
Haploinsufficiency Scores
- pHI
- 0.462
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.538
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.909
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nckap1l
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; liver/biliary system phenotype; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype;
Gene ontology
- Biological process
- cell morphogenesis;B cell homeostasis;myeloid cell homeostasis;chemotaxis;cell migration;maintenance of cell polarity;cell projection assembly;neutrophil chemotaxis;positive regulation of actin filament polymerization;cortical actin cytoskeleton organization;positive regulation of B cell proliferation;activation of protein kinase activity;negative regulation of interleukin-17 production;negative regulation of interleukin-6 production;positive regulation of cell adhesion mediated by integrin;erythrocyte homeostasis;negative regulation of myosin-light-chain-phosphatase activity;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of T cell proliferation;positive regulation of phosphorylation;response to drug;T cell homeostasis;negative regulation of apoptotic process;neutrophil degranulation;positive regulation of CD4-positive, alpha-beta T cell differentiation;positive regulation of CD8-positive, alpha-beta T cell differentiation;positive regulation of GTPase activity;positive regulation of B cell differentiation;positive regulation of gamma-delta T cell differentiation;positive regulation of lymphocyte differentiation;positive regulation of erythrocyte differentiation;vascular endothelial growth factor receptor signaling pathway;neuron projection morphogenesis;erythrocyte development;B cell receptor signaling pathway;positive regulation of phagocytosis, engulfment;protein-containing complex assembly;actin polymerization-dependent cell motility;positive regulation of neutrophil chemotaxis
- Cellular component
- cytosol;plasma membrane;integral component of plasma membrane;membrane;secretory granule membrane;SCAR complex;extracellular exosome;ficolin-1-rich granule membrane
- Molecular function
- GTPase activator activity;protein binding;protein kinase activator activity;protein-containing complex binding;Rac GTPase binding